Radavelli-Bagatini, Simone http://orcid.org/0000-0001-6821-5217
Sim, Marc
Blekkenhorst, Lauren C.
Bondonno, Nicola P.
Bondonno, Catherine P.
Woodman, Richard
Dickson, Joanne M.
Magliano, Dianna J.
Shaw, Jonathan E.
Daly, Robin M.
Hodgson, Jonathan M.
Lewis, Joshua R.
Funding for this research was provided by:
national health and medical research council (nhmrc) of australia emerging leadership investigator grant (1172987)
national heart foundation of australia post-doctoral research fellowship (102498)
national heart foundation of australia future leader fellowship (102817)
national health and medical research council of australia senior research fellowship (1116973)
national health and medical research council investigator grant (1173952)
Edith Cowan University
Article History
Received: 8 July 2021
Accepted: 22 February 2022
First Online: 20 March 2022
Declarations
:
: CPB and JMH report grants from FruitWest, and from Department of Agriculture and Food WA, outside the submitted work. DJM and JES report grants from Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, Eli Lilly Australia, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Roche Diagnostics Australia, Sanofi Aventis and Sanofi-synthelabo, during the conduct of the study. RMD received a Primary Growth Partnership grant via the Ministry of Primary Industries in New Zealand with Fonterra Co-operative Group Ltd, outside the submitted work. All other authors have no potential conflicts of interest to report.
: The study was approved (on March 2nd, 1999) by The Human Research Ethics Committees of the International Diabetes Institute (Melbourne, Australia).
: A written informed consent was obtained from all participants prior to their inclusion in the study in 1999/2000.
: All participants provided informed consent regarding publishing the results of this study.